59 results
Page 2 of 3
8-K
EX-3.1
wowh mwo9nu6uus
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
e2gak88z6flig9jmtn4
16 Apr 21
Submission of Matters to a Vote of Security Holders
4:00pm
425
w2ie2ef8t3
22 Mar 21
Business combination disclosure
5:21pm
S-4/A
jzz3dc
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
S-4
53a034dnn
15 Jan 21
Registration of securities issued in business combination transactions
5:24pm
424B5
vsnz7z964ic
13 Aug 20
Prospectus supplement for primary offering
8:40am
8-K
EX-3.1
sf1l8lees0
27 Jul 20
Departure of Directors or Certain Officers
12:00am
424B5
eev15dem1k40 o33i9b1
18 May 20
Prospectus supplement for primary offering
6:07am
424B5
c50lby6focngugsb
8 Apr 20
Prospectus supplement for primary offering
9:16am
424B4
81bygt 4le
9 Dec 19
Prospectus supplement with pricing info
6:08am
DEFA14A
pscwlb16536nx
5 Dec 19
Additional proxy soliciting materials
11:14am
PRER14A
ixrbqk
4 Dec 19
Preliminary revised proxy
1:33pm